HK Stock Market Move | Joinn Laboratories (06127) rose by more than 7%. Supply of the crab-eating monkeys is still relatively tight. The company's production capacity utilization remains at a high level.

Joinn Laboratories (06127) surged more than 7%, up 7.18% as of the time of writing, at HK$21.04, with a turnover of HK$68.7699 million. On the news front, Joinn Laboratories recently stated at its first quarter 2026 performance briefing that the supply of cynomolgus monkeys in the industry is still tight, and the price fluctuations of experimental monkeys are mainly due to changes in supply and demand structure. Current demand is recovering, while supply remains tight. However, with various uncertainties, the future price trend still requires continuous observation. The company also mentioned that benefiting from the continuous recovery of pharmaceutical research and development demand, the rise in monkey prices can gradually transmit to new signed orders, driving product sales prices upward in sync with changes in market supply and demand. According to data disclosed by Joinn Laboratories, the company achieved new signed orders of approximately RMB 910 million in the first quarter of 2026, a year-on-year increase of 111.6%; as of the end of the first quarter, the company's backlog of orders reached RMB 3.1 billion, a year-on-year increase of 40.9%. The company revealed at the performance briefing that the level of order volume and price in the second quarter continues the momentum of the first quarter. The company's production capacity utilization remains at a high level, but still has some elasticity for flexible acceptance of new orders.